How Is the Trump Administration’s Plan to Lower Drug Prices Going?
The Department of Health and Human Services (HHS) has released a report, “100 Days of Action on the American Patient First Blueprint,” and a factsheet about the Trump Administration’s drug price blueprint. The report notes that:
- 15 drug companies responded to the Trump blueprint.
- 2 have lowered the cost of prescription drugs.
- 13 committed to price freezes for the remainder of 2018.
- 4 canceled planned price increases.
You can read more here.
HHS releases report analyzing first 100 days following the release of the President’s blueprint to lower drug prices; 15 drug companies respond. ASCRS news release August 2018. http://ascrs.org/node/32522.